Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer Therapy
- 4 August 1997
- journal article
- review article
- Published by Wiley in Angewandte Chemie-International Edition
- Vol. 36 (13-14), 1374-1389
- https://doi.org/10.1002/anie.199713741
Abstract
No abstract availableKeywords
This publication has 185 references indexed in Scilit:
- Integrinantagonisten und andere niedermolekulare Verbindungen als Inhibitoren der Angiogenese ‐ neue Wirkstoffe in der TumortherapieAngewandte Chemie, 1997
- Kombinatorische Synthese niedermolekularer organischer VerbindungenAngewandte Chemie, 1996
- Adhesion Properties and Integrin Expression of Cultured Human Osteoclast-like CellsExperimental Cell Research, 1994
- Cysteine pairing in the glycoprotien IIbIIIa antagonist kistrin using NMR, chemical analysis, and structure calculationsBiochemistry, 1993
- αIIbβ3 Integrin expression and function in subpopulations of murine tumorsExperimental Cell Research, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Proton NMR assignment and secondary structure of the cell adhesion type III module of fibronectinBiochemistry, 1992
- ArgGlyAsp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts*1Experimental Cell Research, 1991
- Immunocytochemical distribution of extracellular matrix receptors in human osteoclasts: A β3 integrin is colocalized with vinculin and talin in the podosomes of osteoclastoma giant cellsExperimental Cell Research, 1989
- Cycloenantiomerie und Cyclodiastereomerie 2. Mitteilung. Über cycloenantiomere cyclo‐Hexaalanyle und ein cycloenantiomeres cyclo‐Diglycyl‐tetraalanylHelvetica Chimica Acta, 1964